CoChat
Sign Up
Cited by 341Hormonal and reproductive studiesTreatment of Major DepressionStress Responses and Cortisol

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled Trial

Pope, Harrison G., Cohane, Geoffrey H., Kanayama, Gen, Siegel, Arthur J., Hudson, James I.·2003·American Journal of Psychiatry
DOI 10.1176/appi.ajp.160.1.105
Open this paper in CoChat — free account

Abstract

OBJECTIVE: Testosterone supplementation may produce antidepressant effects in men, but until recently it has required cumbersome parenteral administration. In an 8-week randomized, placebo-controlled trial, the authors administered a testosterone transdermal gel to men aged 30-65 who had refractory depression and low or borderline testosterone levels. METHOD: Of 56 men screened, 24 (42.9%) displayed morning serum total testosterone levels of 350 ng/dl or less (normal range=270-1070). Of these men, 23 entered the study. One responded to an initial 1-week single-blind placebo period, and 22 were subsequently randomly assigned: 12 to 1% testosterone gel, 10 g/day, and 10 to identical-appearing placebo. Each subject continued his existing antidepressant regimen. Ten subjects receiving testosterone and nine receiving placebo completed the 8-week trial. RESULTS: The groups were closely matched on baseline demographic and psychiatric measures. Subjects receiving testosterone gel had significantly greater improvement in scores on the Hamilton Depression Rating Scale than subjects receiving placebo. These changes were noted on both the vegetative and affective subscales of the Hamilton Depression Rating Scale. A significant difference was also found on the Clinical Global Impression severity scale but not the Beck Depression Inventory. One subject assigned to testosterone reported increased difficulty with urination, suggesting an exacerbation of benign prostatic hyperplasia; no other subject reported adverse events apparently attributable to testosterone. CONCLUSIONS: These preliminary findings suggest that testosterone gel may produce antidepressant effects in the large and probably underrecognized population of depressed men with low testosterone levels.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.160.1.105

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Cited by

Sorted by citations

See all 341

Related

Metadata

Authors
Pope, H. G., Cohane, G. H., Kanayama, G., Siegel, A. J., & Hudson, J. I.
Affiliations
Harvard University (US)
ORCID
Venue
American Journal of Psychiatry
Publisher
American Psychiatric Association Publishing
Published
2003-01-01
Volume
160
Issue
1
Pages
105-111
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
DOI
10.1176/appi.ajp.160.1.105
OpenAlex
W2120109795
Cited by
341
References
35
Citations by year
2026: 3 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 5 · 2021: 10 · 2020: 9 · 2019: 9 · 2018: 13 · 2017: 15 · 2016: 11 · 2015: 15 · 2014: 13 · 2013: 21 · 2012: 15
FWCI
10.64
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
testosterone gel, testosterone supplementation, treatment-resistant depression, male depression, androgen deficiency, transdermal testosterone, antidepressant effects, benign prostatic hyperplasia, Hamilton Depression Rating Scale
MeSH terms
Adult, Aged, Antidepressive Agents, Major Depressive Disorder, Double-Blind Method, Drug Therapy, Combination, Gels, Humans, Male, Middle Aged, Testosterone, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review